Loading…
Based on limited metadata, this FDA Warning Letter was issued to Ingenue Care on May 31, 2019, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the precise compliance issues and required corrective actions, review of the complete Warning Letter would be necessary.